grant

Development of an Interleukin-11 Signalling Antagonist [ 2018 - 2020 ]

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/1147621]

Researchers: Dr Michael Griffin (Principal investigator) ,  Dr Tracy Putoczki

Brief description Interleukin (IL)-11 is a soluble signalling molecule that is associated with many types of cancer. We have recently discovered that IL-11 signalling is a novel and tractable therapeutic target for the treatment of colon cancer. The aims of this proposal are to understand the structural details of IL-11 signalling. We will use this information to develop new and improved therapeutics for colon cancer.

Funding Amount $AUD 625,830.15

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]